Menopause

National study halted since health risks exceed benefits in postmenopausal women on estrogen

Published in Women's Health Weekly, July 25th, 2002

Researchers nationwide have halted the part of a 40-center study that involved trying to determine the risks versus the benefits of healthy postmenopausal women taking the hormones estrogen and progestin.

That's because after 5 years of data collection, the study clearly showed the risks outweighed the benefits, scientists said. Taking the combination appears to boost the chance of developing breast cancer somewhat and does not lead to the anticipated benefits in preventing heart attacks and strokes.

The National Heart, Lung and Blood Institute sponsors the continuing, larger project, which is known as the Women's Health Initiative. Institute...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2002-07-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry